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ABSTRACT 
 The pathogenic Escherichia coli EDL933 is known to cause infection in the 
intestine.  E. coli Nissle 1917 is used as a probiotic strain to prevent infection (63).  
When the mouse intestine is pre-colonized with E. coli Nissle 1917 it prevents E. coli 
EDL933 from growing up in the intestine.  E. coli EDL933 is not eliminated from the 
intestine; it stays at the level in which it was fed to the mice.  The P41L envZ 
missense mutation was previously shown to causes an increase in the level of 
phosporylated OmpR (OmpR~P) produced (67).  E.coli MG1655 with the P41L 
missense envZ mutation is referred to as E. coli MG1655 mot-1.  These changes result 
in an improvement of E. coli MG1655 colonization ability in the mouse intestine.  
The EnvZ/OmpR system positively regulates the small RNAs omrA and omrB (29).  
omrA and omrB were shown to negatively regulate a number of outer membrane 
genes including ompT, cirA, fepA, and fecA, (29).  omrA and omrB work by 
hybridizing to mRNA thereby preventing translation from occurring (28).  The 
mutant envZ gene was transferred to E. coli Nissle 1917 to create E. coli Nissle 1917 
envZ(mot-1).  The mutant envZ gene results in E. coli Nissle 1917 having improved 
colonization ability.  E. coli Nissle 1917 envZ(mot-1) grows slower than E. coli 
Nissle 1917 wildtype on many sugars and in cecal mucus.  The E. coli Nissle 1917 
envZ(mot-1) mutant grows slower on galactose than E. coli Nissle 1917 wildtype.  
When the ability to utilize galactose is eliminated from E. coli Nissle 1917 envZ(mot-
1) it can no longer grow up in the mouse intestine in the presence of E. coli Nissle 
1917 wildtype.  This displays the importance of galactose utilization in the intestine 
for E. coli Nissle 1917 envZ(mot-1).  E. coli Nissle 1917 envZ(mot-1) may have 
access to a niche where galactose is being utilized that E. coli  Nissle 1917 is unable 
to inhabit.  If E. coli Nissle 1917 was able to inhabit that niche then it would seem 
likely that E. coli Nissle 1917 would out compete E. coli Nissle 1917 envZ(mot-1) 
due to its superior ability to utilize galactose.  E. coli Nissle 1917 envZ(mot-1) was 
then colonized against E. coli EDL933 to see if its improved colonization ability also 
results in improved probiotic potential.  After performing multiple colonization 
experiments it is evident that E. coli Nissle 1917 envZ(mot-1) is not a better probiotic 
than E. coli Nissle 1917 wildtype. 
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 2 
INTRODUCTION 
When a bacterial species persists indefinitely in the mouse intestine without 
repeated introduction, the animal is said to be colonized by the bacterium (39).  
Commensal strains colonize the intestine in the presence of at least 500 cultivable 
species and 1013 to 1014 total bacteria (19).  E. coli colonization cannot be studied in 
the conventional animal due to the fact that colonization resistance occurs when every 
niche is filled by the microbiota (15).  A model where open niches are available for E. 
coli to colonize in relatively high numbers and also mimic the conventional animal is 
required to perform such experiments.  The streptomycin treated-mouse model fulfills 
these criteria and is used routinely in the mouse colonization experiments (16, 38). 
When streptomycin treated-mice are colonized with motile E. coli MG1655 
80-90% lack flagella and are non-motile 7 to 9 days after feeding (27, 41).  The non-
motile mutants have deletions of various sizes beginning downstream of an IS1 
element in the flhDC regulatory region and extending into or beyond the flhDC 
structural genes (27, 41).  FlhD and FlhC form the FlhD4C2 complex (7, 43, 72), 
which activates transcription of class II flagellar genes that encode components of the 
flagellar basal body and export machinery (52).  The IS1 element upstream of the 
flhDC promoter increases expression of the flhDC operon which causes E. coli 
MG1655 to be hyper-motile (6, 27).  The flhDC deletion mutants were found to grow 
faster than the parent strain in mouse cecal mucus and sugars found in the mucus 
layer of the intestine (27, 41) which may account for its selection in the intestine.  
Studies suggest that the E. coli MG1655 flhDC operon deletion mutants utilize sugars 
better than their parent strain because a number of metabolic genes are repressed by 
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the FlhD4C2 regulatory complex as well as a large number of sugar catabolism 
operons (22, 53, 54).  Also, increased energy is available for other processes due to 
the absence of hyper flagella synthesis and rotation (27).  10-20% of the E. coli 
MG1655 remained motile over a 15 day period (27) which suggests that they were 
also better colonizing mutants or that they were residing in an intestinal niche where 
motility provides an advantage (39).  The 10-20% of E. coli MG1655 that remained 
motile were found to be envZ missense mutants that display an increased colonization 
ability (39). 
The envZ missense mutant that was studied further was the P41L mutant (ccg 
to tcg), which is a mutation in the N-terminal transmembrane domain of EnvZ (39).  
The mutant is referred to as E. coli MG1655 mot-1.  There are two major small 
molecule porins in the E. coli outer membrane, OmpF and OmpC.  OmpF is the major 
porin present at low osmolarity in the outer membrane of E. coli and OmpC becomes 
the predominant porin present at high osmolarity (24).  Where the two porins differ 
are size of the pore and the flow rates, the smaller pore is encoded by ompC (24).  
Regulation of ompF and ompC is carried out by the two-component EnvZ/OmpR 
system (24, 25).  EnvZ is a sensory histidine kinase that is located on the inner 
membrane that modulates gene expression in response to osmolarity; it is 
autophosphorylated via gamma phosphate of cytoplasmic ATP on a histidine residue 
(24, 71).  The phosphoryl group is then transferred from EnvZ to an aspartic acid 
residue on OmpR, the response regulator, and phosphorylated-OmpR (OmpR~P) 
alters the expression of ompF and ompC by binding to sites in their promoters (24) as 
depicted in Fig 1.  The P41L replacement in EnvZ previously was shown to result in 
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higher than normal levels of OmpR~P (67).  OmpR~P regulates several genes (28, 
57).  The P41L mutation altered several phenotypic traits in the E. coli MG1655 mot-
1, which resulted in improved mouse intestinal colonization ability (39).  E. coli 
MG1655 mot-1 grew faster on several sugars relative to the wildtype and as stated 
above, also colonized the mouse intestine better than the wildtype (39).  The P41L 
envZ missense mutation resulted in E. coli MG1655 mot-1 being much more resistant 
to 5% bile salts than the wildtype parent strain due to the down regulation of the porin 
that transports bile salts, OmpF (39).  The EnvZ/OmpR signal transduction system 
also regulates omrA and omrB, two small RNAs that negatively regulate the 
expression of several outer membrane proteins including CirA, which is the receptor 
for colicin V (11).  Since E. coli MG1655 mot-1 appeared to have higher levels of 
OmpR~P that should result in reduced levels of CirA in the outer membrane, it 
seemed that they may perhaps be more resistant to the action of colicin V (39).  
Indeed, E. coli F-18, which produces colicin V (44), inhibited the growth of E. coli 
MG1655, to a greater extent than it inhibited the growth of E. coli MG1655 mot-1 
(39).  Furthermore, since omrA and omrB also negatively regulate expression of a 
number of other outer membrane proteins (29) such as CsgD (regulator of Curli 
biosynthesis), it is likely that the outer membrane of E. coli MG1655 mot-1 differs 
markedly from the wildtype (39). 
Although E. coli MG1655 mot-1 is a better colonizer than the E. coli MG1655 
∆flhD non-motile mutant selected by the mouse intestine, it grew 15% slower than E. 
coli MG1655 ∆flhD in cecal mucus in vitro and on several carbon sources in vitro but 
grew 30% faster on galactose.  In addition, despite its slower growth in mouse cecal 
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mucus, E. coli MG1655 mot-1 appeared to colonize one intestinal niche just as well 
as E. coli MG1655 ∆flhD where factors other than nutrition must be responsible and 
appeared to use galactose to colonize a second intestinal niche in the cecum that is 
either not colonized or colonized poorly by E. coli MG1655 ∆flhD (39). 
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a pathogenic strain 
that causes disease in humans when infection occurs and it has virulence factors such 
as adhesins and toxins (22, 36).  Probiotic bacterial strains are used to colonize the 
intestine and they can prevent a pathogenic strain from colonizing if they are already 
established in the niche that a pathogen could potentially inhabit.  Since the early 
1920s E. coli Nissle 1917, a human commensal strain, has been utilized as a probiotic 
(63); however, E. coli Nissle 1917 does not completely stop the EHEC strain E. coli 
EDL933 from colonizing the mouse intestine (40).  A P41L change in the envZ gene 
of E. coli MG1655, a normal human commensal strain, has been shown to modify its 
nutrition profile, outer surface protein composition, and to improve its mouse 
intestinal colonizing ability (39).  Here we test if replacing the E. coli Nissle 1917 
wildtype envZ gene with the E. coli MG1655 mot-1 envZ gene will improve its 
intestinal colonizing ability and its probiotic potential and possibly allow it to stop the 
pathogen E. coli EDL933 from colonizing the intestine and causing infection. 
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MATERIALS AND METHODS 
Bacterial strains.  Bacterial strains used in this study are listed in Table 1.  
The original E. coli strain K-12 was obtained from a stool sample from a 
convalescing diphtheria patient in Palo Alto, CA, in 1922 (4).  The sequenced E. coli 
MG1655 strain (CGSC 7740) was derived from the original K-12 strain, having only 
been cured of the temperate bacteriophage lambda and the F plasmid by means of UV 
light and acridine orange treatment (4).  It has an IS1 element in the flhDC promoter 
(10).  E. coli Nissle 1917 has been marketed as a probiotic remedy against intestinal 
disorders in several European countries since the 1920s (59).  The allelic exchange 
method described by Datsenko and Wanner (18) was used to construct E. coli Nissle 
1917 envZ(mot-1) ∆galK::cat (Table 1), which contains a 912 bp deletion, replaced 
by a chloramphenicol cassette beginning 153 bp downstream of the ATG start codon 
and ending 78 bp upstream of the TGA stop codon.  As expected, E. coli Nissle 1917 
StrR envZ(mot-1) ∆galK::cat, failed to grow in M9 minimal medium containing 0.4% 
(w/v) galactose as sole carbon and energy source.  E. coli Nissle 1917 envZ(mot-1) 
∆galK::cat was restored to Gal+ by allelic replacement (18), selecting for restored 
growth on M9 minimal galactose agar plates.  The restored Gal+ grew at the same rate 
as E. coli Nissle 1917 envZ(mot-1) in M9 galactose minimal medium.  The wildtype 
envZ gene in E. coli Nissle 1917 was replaced with the E. coli MG1655 mot-1 envZ 
gene using an allelic replacement strategy developed by Dr. Barry Wanner and Dr. 
Kiryl Datsenko at Purdue University as described previously (39) and see sequencing 
and primes section.  All constructions were confirmed by sequencing.  
Bacterial Plasmids.  Plasmids used in this study are listed in Table 2. 
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Colicin V sensitivity. E. coli F-18 produces colicin V (44).  E. coli MG1655 
strains tested for sensitivity to colicin V were grown overnight in LB broth Lennox at 
37°C with shaking in 125-ml tissue culture bottles.  The next day, 106 CFU of each 
strain tested was added to 3 ml of Luria broth Lennox containing 7g/L Difco agar 
(soft agar), which was then poured onto a 20-ml Luria broth Lennox agar plate.  After 
the soft agar on each plate solidifies, E. coli F-18 colonies were toothpicked to each 
plate, incubated for 18 h at 37°C, and zones of growth inhibition were measured (39). 
Motility. Motility of E. coli MG1655 strains was assayed by toothpicking 
colonies from LB agar Lennox onto Luria motility agar (3.5 g/l) containing 200 mM 
NaCl (5).  Plates were incubated for 6 h at 37°C after which spreading was measured 
from the edge of each colony. 
Media and growth conditions. LB broth Lennox (Difco Laboratories, 
Detroit, MI), LB agar Lennox (Difco), and MacConkey agar (Difco) were used for 
routine cultivation.  SOC medium was prepared as described by Datsenko and 
Wanner (18).  For testing carbon and energy source utilization, M9 minimal medium 
(46) was modified by addition of 120 mM NaCl, to more closely approximate the 
sodium chloride concentration in the intestine (5).  Growth also was tested in cecal 
mucus (2.5 mg protein /ml) in HEPES-Hanks buffer (pH 7.0), which contains 137 
mM NaCl, the sodium chloride concentration in jejunal and ileal intestinal fluid (5).  
Cultures were prepared and growth was monitored spectrophotometrically (A600) with 
a Pharmacia Biotech Ultrospec 2000 UV/Visible Spectrophotometer (41).  
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Isolation of cecal mucus and growth.  Mouse cecal mucus was isolated as 
previously described (14). Briefly, mice (5 to 8 weeks old) were fed Teklad mouse 
and rat diet (Harlan Laboratories, Madison, WI) for 5 days after being received.  The 
drinking water was then replaced with sterile distilled water containing streptomycin 
sulfate (5 g/L), the concentration of streptomycin water given to the mice during 
colonization experiments so the conditions in the intestine were consistent with the 
conditions that occurred during colonization experiments.  Twenty-four hours later, 
the mice were sacrificed by CO2 asphyxiation and their ceca were removed.  The 
cecal contents were washed out with sterile distilled water and cecal mucus was 
scraped into HEPES-Hanks buffer (pH 7.0), centrifuged, and sterilized by UV 
irradiation as described previously.  The concentration of the mucus was determined 
using the Bradford Assay and measured spectrophotometrically using the Pharmacia 
Biotech Ultrospec 2000 Visible Spectrophotometer; the cecal mucus was diluted to 
2.5 mg/mL in HEPES-Hanks buffer (pH 7.0).  Then growth was measured 
spectrophotometrically (A600).  All animal protocols were approved by the University 
Committee on Use and Care of Animals at the University of Rhode Island.  (14).   
Growth in the presence of 5% bile salts.  Strains to be tested for bile salts 
sensitivity were grown overnight in LB broth Lennox, diluted to an A600 of about 0.1 
into fresh LB broth Lennox containing 5% (w/v) Bacto-Bile Salts No. 3 (Difco 
Laboratories) and incubated at 37°C with shaking in 125 ml tissue culture bottles 
(39).   Growth was monitored spectrophotometrically (A600) with a Pharmacia 
Biotech Ultrospec 2000 UV/Visible Spectrophotometer (41).  
 9 
 Sequencing and primers. DNA sequencing was done at the URI Genomics 
and Sequencing Center, University of Rhode Island, Kingston, using the Applied 
Biosystems 3130xl Genetic Analyzer (Applied Biosystems, Foster City CA).  A 
BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) was used in the 
sequencing reactions (39). 
 The galK deletion primers used to make E. coli Nissle 1917 envZ(mot-1) 
∆galK::cat (uppercase letters, E. coli Nissle 1917 DNA; lowercase letters, 
chloramphenicol resistance cassette DNA) were as follows: primer 1, 5′ -  AAA 
CGTAAAAAGTCTCTTTAATACCTGTTTTTGCTTCATATTGTTCAGC 
gtgtaggctggagctgcttcg-3′; primer 2, 5′- CGACTACAACGACGGTTTCGTTCTG 
CCCTGCGCGATTGATTATCAAACCcatatgaatatcctccttagt-3′. The primers used for 
both amplifying the galK::cat deletion for allelic exchange into E. coli Nissle 1917 
envZ(mot-1) and for sequencing to confirm its presence in E. coli Nissle 1917 
envZ(mot-1) ∆galK::cat were: forward primer (43 bp upstream of the galK coding 
sequence), 5'-AACAGGCAGCAGAGCGTTTGC-3'; and reverse primer (53 bp 
downstream of the galK coding sequence), 5'-AGTCCATCAGCGTGACTACCATC-
3'.  The same primers were used for the replacement of the ∆galK::cat mutation in E. 
coli Nissle 1917 envZ(mot-1) ∆galK::cat with the wildtype galK gene and for 
confirmation of the replacement. 
In construction of E. coli Nissle 1917 envZ(mot-1) the first step replaced the 
E. coli Nissle 1917 wildtype envZ with a cassette encoding kanamycin resistance (2) 
and parE under control of the rhamnose promoter (kan-rhaP-parE).  The forward 
primer used was 5' - 
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TTCATTATCAATCAATTGAAAACAATCTAAAAACGGGAGGCACCTT 
CACCTCCCGTTTTTTTACCCTTCTTTTGT CTCCCGCTCAGAAGAACTCGTC - 
3' (The first 47 basepairs are in the 700 basepair region that occurs upstream of envZ).  
The reverse primer was 5’- 
GCTTCTCGCCACGAAGTTCATTTGCCCGTACGTTATTGC 
TCATCGTCACCTTGCTGTTCGGGATCCAATCAGCCCTTGAG - 3’ (which is 3 
basepairs upstream of ompR).  These primers have homology to E. coli Nissle 1917 
and the kanamycin parE cassette.  The parE gene encodes a DNA gyrase inhibitor, 
i.e., the toxin of a toxin anti-toxin pair that kills the cell when produced in the absence 
of its cognate antitoxin.  The second step replaced the kan-rhaP-parE cassette with 
the E. coli MG1655 mot-1 envZ allele by selecting for growth on M9 minimal agar 
plates containing 1.0 % w/v rhamnose (which would otherwise kill when rhamnose 
induces ParE).  The forward primer used was 5’ - 
CTTTTGCAAGCGAATCCTTTCATTATCAA 
TCAATTGAAAACAATCTAAAAACGGGAGGCACCTTCACCTCCCGTTTTTTT 
ACCCTTCTTTTGT CGTGC - 3' (the 5’ end matches Nissle 1917’s envZ and the 3’ 
end matches MG1655 so the P41L envZ can be amplified in E. coli MG1655 mot-1).  
The reverse primer was 5’- TCGACGTGCAGATTTCGCGT -3’ (located 105 
basepairs downstream of envZ).  The double recombination event leaves no scars on 
the genome. All constructions were confirmed by sequencing.  The primer 1,  5’ - 
GGTTTACGTCAGCAAGATTTTGC- 3’ (which begins 158 basepairs upstream of 
envZ and primer) 2, 5’ - TCGACGTGCAGATTTCGCGT – 3’ (105 basepairs 
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downstream of envZ) were used to restore the wildtype E. coli Nissle 1917 envZ gene 
to E. coli Nissle 1917 envZ(mot-1). 
 Mouse colonization experiments.  The specifics of the streptomycin-treated 
mouse model used to compare the large intestine colonizing abilities of E. coli strains 
in mice have been described previously (44, 49, 64, 65, 70).  Briefly, sets of three 
male CD-1 mice (5 to 8 weeks old) were given drinking water containing 
streptomycin sulfate (5 g/L) for 24 h to eliminate resident facultative bacteria (45).  
Following 18 h of starvation for food and water, the mice were fed 1 ml of 20% (w/v) 
sucrose containing 105 CFU or 1010 CFU of LB broth Lennox-grown E. coli strains.  
After ingesting the bacterial suspension, both the food (Teklad mouse and rat diet; 
Harlan Laboratories, Madison, WI) and streptomycin-water were returned to the mice, 
and 1 g of feces was collected after 5 h, 24 h, and on odd-numbered days at the 
indicated times.  Mice were housed individually in cages without bedding and were 
placed in clean cages at 24-h intervals.  Individual fecal pellets were therefore no 
older than 24 h.  Each fecal sample (1 gram) was homogenized in 10 ml of 1% Bacto-
Tryptone (Difco), diluted in the same medium, and plated on MacConkey agar plates 
with appropriate antibiotics.  When appropriate, 1 ml of a fecal homogenate (sampled 
after the feces had settled) was centrifuged at 12,000 x g, resuspended in 100 µl of 
1% Bacto-Tryptone, and plated on a MacConkey agar plate with appropriate 
antibiotics.  This procedure increases the sensitivity of the assay from 102 CFU/gram 
of feces to 10 CFU/per gram of feces.  To distinguish the various E. coli strains in 
feces, dilutions were plated on lactose MacConkey agar containing the appropriate 
antibiotics.  All plates were incubated for 18 to 24 h at 37°C prior to counting (39).   
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Polymerase Chain Reaction.  In order to amplify DNA segments PCR was 
utilized.  The Eppendorf Master Cycler 5331 Gradient PCR Thermocycler was used 
(Westbury, NY).  The primers were ordered from Integrated DNA Technologies 
(Coralville, IA).  The DNA polymerase used in the PCR reactions was Taq DNA 
polymerase (New England Biolabs, Ipswich, MA).  Conditions used in PCR reactions 
were, 950C for five minutes for the initial denaturation step, then 950C for 30 seconds 
for denaturation, 550C for 30 seconds for the annealing step, and 720C for three 
minutes and 30 seconds extension step, with the annealing and extension steps 
repeating 34 times, and ending with a 720C 10 minute final extension for all PCRs 
except for the primers   5’ -  
CTTTTGCAAGCGAATCCTTTCATTATCAATCAATTGAAAACAATCTAA 
AAACGGGAGGCAC CTTCACCTCCCGTTTTTTTACCCTTCTTTTGTCGTGC – 
3’ and 5’ – TCGACGTGCAGATTTCGCGT -3’ used in amplifying the P41L envZ in 
E. coli MG1655 mot-1.  With these two primers the 950C denaturation step was 15 
seconds rather than 30, and the 550C annealing step was 45 seconds rather than 30 
seconds.  All PCR products were visualized on 1% agarose (Fisher Biotec) gels 
(Wembley, WA). 
Preparation of genomic DNA.  10 mL cultures were grown overnight in LB 
broth at 370C.  The genomic DNA was isolated using the Promega Wizard Genomic 
DNA isolation kit (Catalog # A1120 Promega Corporation, Madison, WI).  Once 
isolated the DNA was then stored at -200C.  In order to isolate plasmids, the culture of 
bacteria containing the plasmid was grown overnight as stated previously, then the 
Eppendorf Fast Plasmid Mini kit (#955150601 Brinkman Instruments Inc, Westbury, 
 13 
NY) was used to isolate the plasmid.  Ethanol precipitation (3) was used to 
concentrate the DNA.  First the DNA was divided into equal parts then one tenth the 
volume of sodium acetate pH 5.4 (Sigma) was added to the DNA.  Next 95% ethanol 
(Quantum Chemical Co., Tuscola, IL) (in the amount of double the total volume of 
DNA and sodium acetate) was added.  The DNA was then allowed to precipitate for 
24 hours at 40C.  After that the precipitated DNA was pelleted in a microcentrifuge 
for 10 minutes at 13,000 x g.  The supernatant was then removed and 500 µL of 70% 
ethanol was added to the DNA to wash it and it was centrifuged again for 2 minutes 
at 13,000 x g.  Next the supernatant was discarded and the pellet was allowed to air 
dry for ten minutes.  The DNA was then resuspended in 4 µL of Molecular Biology 
Grade PCR water (Fisher Scientific, Pittsburgh, PA).  The precipitated DNA was then 
stored at -200C.  In order to determine the concentration of DNA, the NanoDrop 1000 
(Thermo Fisher Scientific) spectrophotometer was used.  To blank the machine 2 µL 
of PCR water was used and then 2 µL of DNA sample was loaded onto the machine 
in order to obtain the concentration.  In order to purify DNA for sequencing purposes 
the QIAGEN QIA quick PCR Purification Kit (# 28104) was used. 
Transformation.  10 mL of culture was grown at 370C in LB medium to an 
A600 of 0.600 absorbance units.  1.8 mL of cells were then pelleted at 10,000 x g in a 
microcentrifuge for 2 minutes at 40C.  The supernatant was then discarded and the 
cells were washed and resuspended twice in cold 10% glycerol, and the final 
resuspension was in 100 µL of cold 10% glycerol (competent cells).  2 µL of DNA 
was mixed with 50 µL of competent cells in an electoporation cuvette (QIAGEN, 
Inc).  The conditions the cells were electroporated at were as follows 2.5 kV, 25 µF, 
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and 200 Ω using the BI0-RAD Gene Pulser Xcell electroporator (Model #: 165-2662, 
Hercules, CA).  This first transformation was done by adding pKD46 to competent 
cells.   pKD46 is a temperature sensitive plasmid and therefore cells derived from 
replication above 300C will no longer have it (18).  The pKD46 plasmid contains a λ 
Red recombinase gene, which is controlled by an arabinose inducible promoter, and 
greatly increases recombination events (18).  The cells were then allowed to recover 
adding 1 mL of LB and incubating at 300C (shaking 200 rpm) for approximately 2 
hours and then 100 µL of cells was plated onto LB plates containing 100 µg/mL of 
ampicillin, the plates were then incubated at 300C.  Once a strain had the pKD46 
plasmid it was then grown at 300C for transformation in 10 mL of SOB medium 
containing 100 µg/mL of ampicillin and 20 mM L-arabinose.  The cells were then 
transformed in the same manner using a deletion cassette, except the DNA was now 
recovered in SOB medium as described in (30), with the addition of 20mM glucose 
(SOC) and cells were plated on LB containing kanamycin (80 µg/mL) or 
chloramphenicol (30 µg/mL) depending on the resistance genes contained in the 
cassette used to eliminate the gene of interest.  SOB is a rich medium that improves 
transformation efficiency (30).  Next transformation was performed again using 
pKD46, to improve transformation efficiency.  In order to restore a gene using the 
pKD267 parE rhamnose cassette encoding kanamycin resistance, the strain was then 
recovered in M9 minimal medium with 0.2% glycerol and after 2 hours of recovery it 
was pelleted in a microcentrifuge at 13,000 x g for 2 minutes.  The supernatant was 
then discarded and it was resuspended in 100 µL of M9 and plated on M9 containing 
1% rhamnose (w/v).  The parE gene, which encodes a DNA gyrase inhibitor; in the 
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presence of rhamnose the parE toxin is present in the absence of its antitoxin thereby 
killing cells that contain the pKD267 parE rhamnose cassette (35).  The cells with the 
restored gene no longer contained the pKD267 plasmid and were thus selected for on 
M9 1% (w/v) rhamnose plates. 
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RESULTS 
E. coli Nissle 1917 envZ(mot-1) displays phenotypic traits seen in E. coli 
MG1655 mot-1.  When E. coli MG1655 undergoes the envZ P41L mutation in the 
mouse intestine to become E. coli MG1655 mot-1, many phenotypic changes occur 
including reduced motility, reduced sensitivity to colicin V, and reduced sensitivity to 
bile salts.  Several experiments were performed with E. coli Nissle 1917 envZ(mot-1) 
in order to determine whether it displayed the same phenotypic traits as E. coli 
MG1655 mot-1.  The motility assay was performed with E. coli Nissle 1917 
envZ(mot-1) and E. coli Nissle 1917 wildtype (Table 3).  When E. coli Nissle 1917’s 
envZ gene was swapped for the E. coli MG1655 mot-1 envZ gene, reduced motility 
occurred.  When E. coli Nissle 1917 envZ(mot-1) was restored to wildtype in terms of 
the envZ gene, its motility increased again to the level of the wildtype, showing the 
mutated envZ gene was responsible for the change in motility (Table 3).  Table 4 
displays the reduced sensitivity to colicin V that E. coli Nissle 1917 envZ(mot-1) 
displays in comparison to the wildtype.  When E. coli Nissle 1917 envZ(mot-1) was 
restored to wildtype, its sensitivity to colicin V increased and returned to the level of 
the wildtype showing that the E. coli MG1655 mot-1 envZ gene was responsible for 
the change in colicin V sensitivity (Table 4).  E. coli Nissle 1917 envZ(mot-1) also 
showed a reduced sensitivity to bile salts.  In the presence of 5% bile salts E. coli 
Nissle 1917 and E. coli Nissle 1917 envZ(mot-1) cells began to lyse at the fourth hour 
in the experiment; however E. coli Nissle 1917 envZ(mot-1) was able grow to a 
higher optical density than E. coli Nissle 1917 wildtype.  By the fourth hour of 
growth in 5% bile salts, E. coli Nissle 1917 envZ(mot-1) reached an optical density of 
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approximately 0.6, whereas E. coli Nissle 1917 reached an optical density of 0.3 
before lysis initiated.  Once restored to wildtype, E. coli Nissle 1917 envZ(mot1) 
restored began to lyse at an optical density of 0.3 again.  Therefore, the P41L 
mutation in envZ resulted in decreased sensitivity to bile salts in E. coli Nissle 1917 
envZ(mot-1). 
E. coli Nissle 1917 envZ(mot-1) is a better colonizer than E. coli Nissle 
1917 wildtype.  When 105 cfu of E. coli Nissle 1917 envZ(mot-1) and 105 cfu of E. 
coli Nissle 1917 wildtype were fed simultaneously to mice, by day 3 E. coli Nissle 
1917 envZ(mot-1) was 2 orders of magnitudes higher than the wildtype in the mouse 
intestine, by day 15 it was still an order of magnitude above the wildtype (Fig. 3).  As 
shown in Fig. 4, low numbers of E. coli Nissle 1917 envZ(mot-1) were able to grow 
up in the presence of high numbers of E. coli Nissle 1917 in the mouse intestine.  In 
addition, low numbers of E. coli Nissle 1917 failed to grow up in the presence of high 
numbers of E. coli Nissle 1917 envZ(mot-1), i.e. by day 15 E. coli Nissle 1917 was 
almost eliminated from the intestine, at around 102  cfu/gram of feces (Fig. 5).  
Furthermore, E. coli Nissle 1917 envZ(mot-1) restored to wildtype co-colonized 
equally well with E. coli Nissle 1917 wildtype simultaneously at  about 105 cfu/gram 
of feces (Fig. 6).  These data suggest that the P41L envZ gene was responsible for E. 
coli Nissle 1917 envZ(mot-1)’s improved colonization ability.   
E. coli Nissle 1917 envZ(mot-1) utilizes galactose to gain an advantage in 
the intestine.  As shown in Fig. 7, when E. coli Nissle 1917 envZ(mot-1) ∆galK, a 
mutant that cannot utilize galactose, was fed to mice in low numbers (105 cfu) against 
high numbers of E. coli Nissle 1917 wildtype (1010 cfu) it failed to grow up in the 
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intestine, however it was not washed out from the intestine, E. coli Nissle 1917 
envZ(mot-1)  ∆galK maintained at 105 cfu per gram of feces.  This suggests that E. 
coli Nissle 1917 envZ(mot-1) used galactose in order to grow up in the intestine in the 
presence of high numbers of E. coli Nissle 1917 wildtype, i.e. when E. coli Nissle 
1917 envZ(mot-1) was able to use galactose, it grew to within 2 orders of magnitude 
of wildtype E. coli Nissle 1917 (Fig. 4).  When E. coli Nissle 1917 envZ(mot-1) 
∆galK restored to wildtype in respect to ∆galK was fed to mice at 105 cfu and E. coli 
Nissle 1917 wildtype was fed to mice at 1010 cfu, E. coli Nissle 1917 envZ(mot-1) 
∆galK restored was able to grow up in the intestine again in the presence of high 
numbers of E. coli Nissle 1917 wildtype (Fig. 8), suggesting that galactose utilization 
was in fact responsible for E. coli Nissle 1917 envZ(mot-1) growing up in the 
intestine in the presence of high numbers of E. coli Nissle 1917 wildtype. 
Growth of E. coli Nissle 1917 envZ(mot-1) on a variety of sugars.  In Table 
5, the generation times for E. coli Nissle 1917 and E. coli Nissle 1917 envZ(mot-1) on 
several carbon sources are listed (arabinose, fructose, fucose, galactose, gluconate, 
glucose, maltose, mannose, N-acetylglucosamine, and ribose).  E. coli Nissle 1917 
envZ(mot-1) and E. coli Nissle 1917 had essentially equal generation times on 5 
carbon sources (arabinose, fructose, fucose, N-acetylglucosamine, and ribose).  On 
the other 5 carbon sources (galactose, gluconate, glucose, maltose, and mannose) E. 
coli Nissle 1917 envZ(mot-1) grew slower than the wildtype.  Of the 10 carbon 
sources tested, E. coli Nissle 1917 envZ(mot-1) was either equal to or worse than the 
wildtype, i.e. it did not grow faster than the wildtype on any of the 10 sugars.  This 
was unexpected considering the fact that E. coli Nissle 1917 envZ(mot-1) was a better 
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colonizer than the wildtype.  It should be noted that galactose provides an advantage 
in vivo for E. coli Nissle 1917 envZ(mot-1) (Figs. 4, 7), but in vitro E. coli Nissle 
1917 envZ(mot-1) had a longer generation time on galactose, indicating that factors 
other than nutrition are important in colonization.  Table 5, also depicts the generation 
times of E. coli Nissle 1917 and E. coli Nissle 1917 envZ(mot-1) on cecal mucus.  E. 
coli Nissle 1917 envZ(mot-1) grew slower than the wildtype in cecal mucus which 
further displays the importance of other factors besides nutrition playing a role in the 
intestine. 
Probiotic potential of E. coli Nissle 1917 envZ(mot-1).  Fig. 9 displays a 
colonization experiment in which E. coli Nissle 1917 was pre-colonized in the 
intestine and on day 10, 105 cfu of E. coli EDL933 (pathogenic strain of E. coli) was 
fed to the mice.  E. coli Nissle 1917 wildtype did not completely eliminate E. coli 
EDL933 from the intestine but it stopped it from growing in the intestine and in fact 
E. coli EDL933 dropped two orders of magnitude.  As shown in Fig. 10, when E. coli 
Nissle 1917 envZ(mot-1) was pre-colonized in the intestine and 105 cfu of E. coli 
EDL933 was introduced on day 10, E. coli Nissle 1917 envZ(mot-1) was able to keep 
E. coli EDL933 from growing up in the intestine, but it also was unable to eliminate 
E. coli EDL933.  Moreover, it appeared that E. coli Nissle 1917 envZ(mot-1) was a 
slightly worse probiotic than its wildtype counterpart, since E. coli EDL933 colonized 
slightly higher than 103 cfu/gram of feces. Fig. 11 shows a colonization experiment in 
which both E. coli Nissle 1917 and E. coli Nissle 1917 envZ(mot-1) were fed 
simultaneously to mice and E. coli EDL933 was introduced on day 10, this data also 
suggests that E. coli Nissle 1917 envZ(mot-1) is a better colonizer than E. coli Nissle 
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1917 wildtype.  Even in the presence of both E. coli Nissle 1917 strains, E. coli 
EDL933 was still not eliminated from the intestine, i.e. both failed to inhabit all of the 
niches that E. coli EDL933 may reside in. 
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DISCUSSION 
When a bacterial species indefinitely persists in stable numbers in the intestine 
of an animal, without repeated introduction, the animal is, by definition, colonized by 
the bacterium.  Commensal E. coli strains colonize the human intestine in the 
presence of a dense and diverse intestinal microbiota comprised of at least 500 
cultivable species and 1013 to 1014 total bacteria (19).  Unfortunately, E. coli 
colonization cannot be studied experimentally in conventional animals due to 
colonization resistance, which results when all niches are filled by the microbiota 
(15).  Such experiments require an animal model with open niches for E. coli to 
colonize in relatively high numbers, but the animal model intestine should have a 
dense and diverse anaerobic community that matches as closely as possible the native 
microbiota of the conventional animal in order to examine interactions among 
members of the microbiota.  The streptomycin-treated mouse model is used routinely 
for this purpose since it fulfills these criteria (16, 38). 
This study was undertaken to determine whether the envZ(mot-1)
 
gene, 
selected in E. coli MG1655 mot-1 by the streptomycin-treated mouse intestine (39), 
would make the probiotic strain, E. coli Nissle 1917, a better mouse intestine 
colonizer and better able to resist colonization by E. coli EDL933, an 
enterohemhorragic strain.  The data presented here clearly show that despite being a 
10-fold better colonizer than E. coli Nissle 1917 and despite appearing to colonize an 
intestinal niche not colonized by E. coli Nissle 1917,  E. coli Nissle 1917 envZ(mot-1) 
is not better than E. coli Nissle 1917 at limiting E. coli EDL933 growth in the 
intestine (Fig. 10).  
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The concept that nutrient availability dictates community structure of the 
intestine was originally presented in Freter’s nutrient-niche hypothesis, which states 
that species coexist in the intestine because each is able to grow faster than all others 
on one or a few limiting nutrients and that the rate of growth of each species during 
the colonization process is at least equal to its washout rate from the intestine (26).  
The hypothesis assumes that all nutrients are perfectly mixed and that they are 
equally available to all species present in the intestine.  According to the hypothesis, 
two strains cannot coexist in the intestine when one competes less well than the other 
for the same nutrient(s) unless the metabolically less efficient one adheres to the 
intestinal wall (26).  As a corollary to the hypothesis, when two strains each use one 
or more major nutrients better than the other strain, low numbers of each strain will 
grow up in the intestine to higher numbers in the presence of high numbers of the 
other strain, as observed in mouse colonization studies using a number of human fecal 
E. coli strains isolated from different humans (40). 
Despite general acceptance of the nutrient-niche hypothesis, recent data 
suggests that it is not entirely correct for E. coli (39).  We recently reported that E. 
coli MG1655 mot-1, selected by the mouse intestine as a better colonizer than E. coli 
MG1655, colonizes as well as E. coli MG1655 ∆flhD, also a better colonizer selected 
by the mouse intestine, but grows less well than E. coli MG1655 ∆flhD in bacteria-
free mouse cecal mucus in vitro and on several sugars present in cecal mucus (39). 
These results were in contrast to what would be expected if the nutrient-niche 
hypothesis were entirely correct as discussed above.  Furthermore, E. coli requires 
mono- and disaccharides for growth in the intestine (16, 38), but mono- and 
 23 
disaccharides present in the diet are unlikely to be available to E. coli because they 
are absorbed in the small intestine.  The anaerobes in the intestine secrete 
polysaccharide hydrolases (33), but E. coli cannot do so (31, 34).  It therefore seems 
likely that E. coli obtains the bulk of the mono- and disaccharides it requires for 
growth in the intestine from degradation by the anaerobes of dietary fiber-derived and 
mucin-derived oligo- and polysaccharides.  In view of this information and since we 
found that E. coli MG1655 resides in mixed biofilms in the mucus layer of the 
intestine, but does not appear to adhere to the intestinal wall, to explain our findings 
we suggested the “Restaurant hypothesis” as a modification to the nutrient-niche 
hypothesis (39).  According to the Restaurant hypothesis, the mono and disaccharides 
that E. coli requires for growth are not derived from the diet and are not perfectly 
mixed in the intestine, but are served locally to E. coli by the anaerobes within the 
mixed biofilms that E. coli inhabits.  The Restaurant hypothesis also raised the 
possibility that E. coli strains with different surfaces (e.g. fimbriae, capsule, O, K, and 
H antigens, outer membrane protein profiles, etc.) might reside in mixed biofilms 
made up of different anaerobes that supply different sugars to those strains, which 
could explain why different E. coli strains display different nutritional programs in 
the intestine despite using the same sugars when cultured in vitro (22, 40).   
The data presented here also are consistent with the Restaurant hypothesis. E. 
coli Nissle 1917 envZ(mot-1) did not grow faster than E. coli Nissle 1917 on any of 
the sugars present in mucus that were tested, grew 10%-30% slower than E. coli 
Nissle 1917 on several of the sugars tested, and grew 50% slower in cecal mucus in 
vitro in which all nutrients were perfectly mixed, i.e. in UV sterilized cecal mucus 
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that had been centrifuged free of bacteria (Table 5).  Yet in contrast to what would be 
expected solely on the basis of competition for nutrients from a mixture that is 
equally available to all, E. coli Nissle 1917 envZ(mot-1) colonized the streptomycin-
treated mouse intestine 10-fold better in competition with E. coli Nissle 1917 (Fig. 3) 
and grew from low to high numbers in the mouse intestine in the presence of high 
numbers of E. coli Nissle 1917 (Fig. 4).  Although these data cannot be explained 
solely by the nutrient-niche hypothesis, since E. coli Nissle 1917 strains appear to 
reside in mixed biofilms in cecal mucus in vivo (M. Mokszycki, unpublished), the 
data can be explained if the lower growth rate of E. coli Nissle 1917 envZ(mot-1) in 
those mixed biofilms relative to E. coli Nissle 1917 is more than compensated for by 
its ability to occupy most of the binding sites in those biofilms, i.e., if E. coli Nissle 
1917 envZ(mot-1)
 
has a greater affinity for biofilm binding sites than E. coli Nissle 
1917.  If so, it is not surprising that when E. coli Nissle 1917 envZ(mot-1) and 
wildtype E. coli Nissle 1917 are fed to mice in equal numbers, E. coli Nissle 1917 
envZ(mot-1) is the better colonizer (Fig. 3). Furthermore, it is not surprising that 
when mice are fed E. coli Nissle 1917 envZ(mot-1) and wildtype E. coli Nissle 1917 
at a ratio of 105:1, that ratio would reach 106:1 with time (Fig. 5).  However, it is 
surprising that when mice are fed wildtype E. coli Nissle and E. coli Nissle 1917 
envZ(mot-1) at a ratio of 105:1, that E. coli Nissle 1917 envZ(mot-1) use galactose to 
grow to higher numbers (Fig. 4 and Fig. 7), despite wildtype E. coli Nissle 1917 
being able to grow faster than E. coli Nissle 1917 envZ(mot-1)
 
on galactose in vitro 
(Table 5). This can be explained if E. coli Nissle 1917 envZ(mot-1) uses galactose to 
grow in a second niche that wildtype E. coli Nissle 1917 cannot colonize. That second 
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niche could be another mixed biofilm consisting of a different group of anaerobes in 
which E. coli Nissle 1917 envZ(mot-1) has a higher affinity for binding sites than E. 
coli Nissle1917 and thereby prevents it from occupying that niche. Alternatively, that 
second niche could be another mixed biofilm that contains an anaerobe that makes a 
bacteriocin or that inhibits wildtype E. coli Nissle 1917 growth more than it inhibits 
E. coli Nissle 1917 envZ(mot-1) growth, much in the same way that E. coli Nissle 
1917 is more sensitive to colicin V than wildtype E. coli Nissle 1917 (Table 4).  
In support of the view that surface differences between E. coli Nissle 1917 
envZ(mot-1) and E. coli Nissle could result in different binding affinities for mixed 
biofilms, when we replaced the envZ gene in E. coli Nissle 1917 with envZ(mot-1), 
three phenotypic changes observed in E. coli MG1655 mot-1 caused by outer 
membrane changes resulting from increased OmpR~P were transferred to E. coli 
Nissle 1917 envZ(mot-1)
.
  These surface changes could contribute to an increased 
affinity for binding sites in a mixed biofilm, i.e., decreased CirA causing increased 
resistance to colicin V (11, 39) (Table 4), and decreased motility (Table 3) caused by 
the negative regulatory effect of increased OmpR~P on the flhDC promoter (60).  It 
has been shown that decreased motility favors biofilm formation following the initial 
adhesion event (8) and that OmpC can serve as an adhesin (55).  It should also be 
mentioned that increased OmpR~P has been shown to stimulate production of curli 
fibers that also stimulate biofilm formation (51).  It therefore seems reasonable that E. 
coli Nissle 1917 envZ(mot-1) could have a higher affinity than E. coli Nissle 1917 for 
binding sites on a mixed biofilm.     
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At the present time we don’t know why despite being a better colonizer than 
E. coli Nissle 1917, E. coli Nissle 1917 envZ(mot-1) is not better at limiting E. coli 
EDL933 colonization than E. coli Nissle 1917; however, the possibility that when E. 
coli EDL933 infects the mouse intestine, it initially grows planktonically in mucus 
and not in mixed biofilms should be considered.  If we are correct that E. coli 
Nissle1917 and E. coli Nissle1917 envZ(mot-1) colonize the mouse intestine by being 
served specific sugars by the anaerobes in the mixed biofilms they inhabit, then small 
amounts of these sugars that escape the mixed biofilms might be available to invading 
E. coli EDL933 as well as to the small numbers of planktonic E. coli Nissle1917 or E. 
coli Nissle1917 envZ(mot-1) that leave the mixed biofilms.  Therefore, it may be that 
both planktonic E. coli Nissle 1917 envZ(mot-1) and E. coli Nissle 1917 compete  
directly with planktonic E. coli EDL933 for the sugars that escape the biofilms or that 
are produced by small numbers of planktonic members of the rest of the microbiota 
that leave the biofilms.  This scenario would allow planktonic E. coli EDL933 to 
colonize to the extent allowed by the available concentrations of those sugars in 
competition with planktonic E. coli Nissle 1917 envZ(mot-1) or E. coli Nissle 1917, 
which could explain why E. coli Nissle 1917, the faster grower in perfectly mixed 
mucus, appears to limit E. coli EDL933 growth in the intestine more than E. coli 
Nissle 1917 envZ(mot-1)
 
(Fig. 9). 
In summary, E. coli Nissle 1917 envZ(mot-1) is a 10-fold better mouse 
intestinal colonizer than E. coli Nissle 1917 despite growing far slower than E. coli 
Nissle 1917 in bacteria-free, perfectly mixed cecal mucus in vitro and on several 
sugars present in mucus, yet is not better at limiting E. coli EDL933 colonization.  
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The data presented here are consistent with the Restaurant hypothesis (39) for 
commensal E. coli strains that colonize the intestine as members of mixed biofilms 
and obtain the sugars they need for growth locally.  However, it may be that it is not 
sessile E. coli that compete for sugars with invading E. coli pathogens but the small 
number of planktonic E. coli that do so.  If so, an efficacious E. coli probiotic agent 
should not only be able to inhabit mixed biofilms better than its parent and as such be 
a better colonizer, but should also be better at utilizing nutrients for growth to 
outcompete the invading pathogen.                                                                                                                          
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APPENDIX 
Background of Escherichia coli. Escherichia coli is a facultatively 
anaerobic, gram negative rod, that is among the enteric bacterial family 
Enterobacteriaceae; it is an inhabitant of the intestinal tract of animals (66).  E. coli is 
a versatile organism that can grow in media containing only glucose as the organic 
component (66).  As Todar states, “Wild-type E. coli has no growth factor 
requirements, and metabolically it can transform glucose into all of the 
macromolecular components that make up the cell.” (66).  E. coli can grow 
aerobically when O2 is available and it can also grow anaerobically in the absence of 
O2 (66).  The EPA states, “E. coli O157:H7 was first recognized as a cause of illness 
during an outbreak in 1982 traced to contaminated hamburgers.” (21).  The EPA also 
states “Since then, most infections are believed to have come from eating 
undercooked ground beef” (21).   
Diseases caused by E. coli O157:H7.  Outbreaks of E. coli O157:H7 occur 
from time to time (13).  They are part of the Shiga toxin-producing E. coli (STEC) 
(13).  The CDC states  “Around 5–10% of those who are diagnosed with STEC 
infection develop a potentially life-threatening complication known as hemolytic 
uremic syndrome (HUS)” (13).  The CDC also states “clues that a person is 
developing HUS include decreased frequency of urination, feeling very tired, and 
losing pink color in cheeks and inside the lower eyelids” (13).  The incubation period 
for sickness with STEC varies, its typically 3-4 days, but it can range from 1-10 days 
(13).  
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 When a person is exposed to STEC infection, frequently one of the initial 
symptoms is belly pain or non-bloody diarrhea (13).  The CDC states “The major 
source for human illnesses is cattle” (13).  Modes of transmission according to the 
CDC are “consumption of contaminated food, consumption of unpasteurized (raw) 
milk, consumption of water that has not been disinfected, contact with cattle, or 
contact with the feces of infected people” (13).  Methods of prevention from infection 
include using a food thermometer to ensure food is safe and not eating high risk foods 
(68).  In case of infection staying hydrated and getting rest helps in overcoming 
infection (68). 
 Colonization of the intestinal tract.  Todar states “E. coli is a consistent 
inhabitant of the human intestinal tract, and it is the predominant facultative organism 
in the human GI tract; however, it makes up a very small proportion of the total 
bacterial content” (66).  When a bacterium reaches a rate of in vivo growth that is 
equal to its rate of removal colonization is said to occur (26).  Host somatic and germ 
cells are believed to be at least one order of magnitude less than the amount of 
microorganisms present in the mucosal surfaces of adult humans (58).  Amongst the 
organisms present in the mucosal surfaces, the most complex population is located in 
the gastrointestinal tract where at least 400 different species of bacteria reside in the 
intestine (9, 23, 58).  Aerobes and facultative species are exceeded by the anaerobes 
to a factor of 1 to 1,000 (48).  Immediately after birth colonization of the gut initiates 
(23).  Bacteria with high multiplication rates are predominant at first when nutrients 
and space are not limited in the intestine, but when space and nutrients begin to 
become limited specialization begins to occur in the intestine and the microbiota 
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becomes more complex (23). The aerobic and anaerobic bacteria present in the birth 
canal are the first inhabitants to populate the human gut (23).  Escherichia coli, 
Clostridium spp., Streptococcus spp., Lactobacillus spp., Bacteroides spp., and 
Bifidobacterium spp are the prevalent species amongst neonates (56).  Among breast 
fed infants, Bifidobacteria form the largest portion of the fecal flora (12).  Differences 
in geographic location results in distinct differences in the composition of the fecal 
flora found between children, displaying the significance of the environment (sanitary 
conditions) (1).  Colonization resistance occurs when all niches in the animal intestine 
are filled by the microbiota; it refers to the complete microbiota’s ability to resist an 
invading bacterium from colonizing the intestine (69).  Administration of an 
antibiotic results in elimination of Enterobacteriaceae from the intestine, opening up a 
niche for the introduction of Escherichia coli (69). 
 The intestine of germ-free animals has been studied and it is compared to the 
intestine of the conventional animal in order to observe the effects that occur with the 
gastrointestinal system.  First observing the behavior of host cells in the absence of 
bacteria, then examining how the addition of a single or defined population affects 
host cell activity is a method used in understanding host-microbe interaction (23).   
Mouse models used to study colonization.  Three in vivo mouse 
colonization models used commonly to study the colonization of bacterial species are 
the conventional mouse model, the germ-free mouse model, and the antibiotic-treated 
mouse model (23, 40).  In the conventional mouse, the complete microbiota is present 
and occupies the intestine (69).  In this model, introducing a bacterial strain into the 
intestine may present difficulty because it must compete with the natural microbiota 
 41 
present.  In the conventional mouse model, introducing a bacterial strain is difficult 
due to colonization resistance (69).  Colonization resistance is not a problem in the 
germ-free mouse model.    The germ-free mouse model differs from the natural 
intestine where there are many organisms present in the intestine.  The data can be 
used to observe the host’s interaction with a specific population but it differs since 
many other microorganisms that are usually present, are absent in the germ-free 
mouse model.  The antibiotic-treated mouse model is often used with 5 g/L of 
streptomycin sulfate being the antibiotic chosen (45).  A large fraction of the bacteria 
in the intestine belong to two phyla, the Firmicutes and the Bacteriodetes (20, 42, 62).  
Extensive microbiological characterization of the microbial community in the 
streptomycin-treated mouse intestine, demonstrated that streptomycin treatment 
removes facultative anaerobes with much less impact on the anaerobes (32).  Any 
strategy to overcome colonization resistance will impact community structure (17, 
61).  The streptomycin-treated mouse model may have an impact on community 
structure but it also eliminates facultative anaerobes, opening a niche and allowing 
bacteria to be studied and competition of a variety of E. coli strains against a dense 
and diverse anaerobe population over an extended period of time (39). 
Use of Probiotics.  Probiotics are live bacteria that may provide health 
benefits when consumed (50).  There is current evidence suggesting that the natural 
microbiota plays a role in the pathogenesis of inflammatory bowel disease (37).  A 
better understanding of the role the natural microbiota plays could potentially help in 
altering the natural microbitota or engineering a new probiotic with the intention of 
alleviating inflammatory bowel disease.  Many mechanisms may be responsible for 
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health benefits involved in probiotic usage (50).  The National Center for 
Complementary and Alternative Medicine states “altering the intestinal 
“microecology” (e.g., reducing harmful organisms in the intestine), producing 
antimicrobial compounds (substances that destroy or suppress the growth of 
microorganisms), and stimulating the body’s immune response” are all possible 
mechanisms that may play a role in the health benefits of probiotics (50).  Several 
gastrointestinal conditions are currently being treated with probiotics including 
diarrhea and inflammatory bowel disease (50).   
Nutrient-niche hypothesis.  The concept that nutrient availability dictates the 
community structure, presented in Freter’s nutrient-niche hypothesis, states that 
species can coexist in the intestine when each is able to grow faster than all others on 
one or a few limiting nutrients and that the rate of growth is at least equal to the 
washout rate from the intestine (26).  The hypothesis assumes that all nutrients are 
evenly mixed and are available to all species throughout the intestine (26).  According 
to the hypothesis, two strains cannot coexist in the intestine when one competes less 
well than the other for the same nutrient(s) unless the metabolically less efficient one 
adheres to the intestinal wall (26). 
The restaurant hypothesis, a modified version of Freter’s nutrient-niche 
hypothesis, is the concept that anaerobes in the mixed biofilms inhabited by E. coli 
provide them with mono- and di- saccharides locally, rather than from a perfectly 
mixed pool available to all species, which is an assumption of the nutrient-niche 
hypothesis (39).  It is further hypothesized that one strain of E. coli can have a higher 
affinity for binding sites on mixed biofilms than a second strain due to differences 
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between the outer surfaces of the two strains (39).  The restaurant hypothesis raises 
the possibility that E. coli strains with vastly different surfaces (e.g. fimbriae, O, K, 
and H antigens etc) reside in biofilms made up of different anaerobes that supply 
different sugars to those strains, which could explain why different E. coli strains 
display different nutritional programs in the intestine (22, 39, 40).  
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Tables: 
 
Table 1  Bacterial strains 
 
 
 
E. coli strain Genotype/phenotype Referred to in text as: Source/Reference 
MG1655 strR 
Spontaneous streptomycin 
resistant mutant of MG1655 MG1655 (47) 
MG1655 strR 
mot-1  
P41L envZ missense mutant of 
MG1655 strR MG1655 mot-1 (39) 
MG1655 ∆flhD 
546-bp deletion beginning 
immediately downstream of IS1 
in the regulatory region of flhD 
and ending in flhD, streptomycin 
and chloramphenicol resistant MG1655 ∆flhD (41) 
Nissle 1917 strR 
Spontaneous streptomycin 
resistant mutant of Nissle 1917 Nissle 1917 (2) 
Nissle 1917 
strRnalR 
Spontaneous nalidixic acid 
resistant mutant of Nissle 1917 
strR Nissle 1917 This study 
Nissle 1917 
strRrifrR 
Spontaneous rifampin resistant 
mutant of Nissle 1917 strR Nissle 1917 This study 
Nissle 1917 strR 
envZ (P41L)  
Nissle 1917 with the envZp41L 
gene in place of its own strR 
Nissle 1917 
envZ(mot-1) This study 
Nissle 1917 
strRnalR envZ 
(P41L) 
Spontaneous nalidixic acid 
resistant mutant of Nissle 1917 
strR envZ(mot-1)  
Nissle 1917 
envZ(mot-1) This study 
Nissle 1917 strR 
envZ (P41L) 
restored  
Nissle 1917 envZ(mot-1) restored 
to wildtype in respect to envZ strR 
Nissle 1917 
envZ(mot-1) restored This study 
Nissle 1917 strR 
envZ (P41L) 
∆galk 
912 bp deletion in galactokinase 
gene replaced by a 
chloramphenicol resistance 
cassette 
Nissle 1917 
envZ(mot-1) ∆galK This study 
Nissle 1917 str R 
envZ (P41L) 
∆galK restored 
Nissle 1917 envZ(mot-1) ∆galK 
restored to wildtype in respect to 
galK  
Nissle 1917 
envZ(mot-1) ∆galK 
restored This study  
Nissle 1917 str R 
nalR envZ (P41L) 
∆galK restored 
Spontaneous streptomycin and 
nalidixic acid resistant mutant of  
Nissle 1917 str R envZ (P41L) 
∆galK restored 
Nissle 1917 
envZ(mot-1) ∆galK This study 
F-18 strRrifR 
Spontaneous streptomycin and 
rifampin resistant mutant of F-18 F-18 (49) 
BW37751 
(pKD267)::KnR 
The plasmid in this strain contains 
parE under control of the 
rhamnose promoter and the 
kanamycin resistance gene pKD267 Barry Wanner 
EDL933  Wild-type O157:H7 strain EDL933 
Dr. Allison O-
Brien 
EDL933 strRrifR 
Spontaneous streptomycin and 
rifampin resistant mutant of 
EDL933 EDL933 This study 
 45 
Table 2 Plasmids 
 
Plasmid  Function Source/Reference 
pKD3 
template plasmid that encodes 
chloramphenicol resistance, flanked by FRT 
sites, which contain FLP recognition target 
sites (18) 
pKD4 
template plasmid that encodes kanamycin 
resistance, flanked by FRT sites, which 
contain FLP recognition target sites (18) 
pkD46 
temperature sensitive, ampicillin resistant, 
contains L-arabinose inducible red 
recombinase.  Promotes DNA recombination. (18) 
pKD267 
a cassette encoding kanamycin resistance (2) 
and parE under control of the rhamnose 
promoter (kan-rhaP-parE). The parE gene 
encodes a DNA gyrase inhibitor, i.e., the toxin 
of a toxin anti/toxin pair that kills the cell when 
produced in the absence of its cognate 
antitoxin (35). Dr. Datsenko and Dr. Wanner 
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Table 3 Motility Assay 
 
E. coli strain Spread (mm) p value 
Nissle 1917 1.1 ± 0.3  
Nissle 1917 envZ(mot-1)   0.6 ± 0.2 p<0.05
 
Nissle 1917 envZ(mot-1) 
restored    1.0 ± 0.1 p>0.05 
 
p values calculated with student’s t test, values  p<0.05 are interpreted as significantly 
different. p>0.05 is interpreted as no significant difference.  p values are relative to 
wildtype E. coli Nissle 1917.  The values are the mean and standard error (n=6).  The 
assay displays the spread on motility agar of each strain in millimeters over 6 hours 
incubated 370 C. 
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Table 4 Colicin Assay 
 
E. coli strain Zone of clearance (mm) p value 
Nissle 1917  2.08 ± 0.62  
Nissle 1917 envZ(mot-1) 
 
 0.17 ± 0.27 p<0.05
 
Nissle 1917 envZ(mot-1)  restored 
 
 2.40 ± 0.33 p>0.05 
 
p values calculated with the student’s t test, values < 0.05 are considered significant 
different. p>0.05 is interpreted as no significant difference.  p values are relative to 
wildtype E. coli Nissle 1917.  The values are the mean and standard error (n=6).  
Colicin assays were performed as described in Materials and Methods. 
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Table  5 Generation times of E. coli Nissle 1917 and E. coli Nissle 1917 envZ(mot-1) 
on various carbon sources 
      
Carbon Source E. coli Nissle 1917 E. coli Nissle 1917 
envZP41L 
arabinose 66 ± 1 64 ± 1*  
fructose 96 ± 4 99 ± 1** 
fucose 83 ± 1 79 ± 4** 
galactose 69 ± 1 81 ± 4*** 
gluconate 61 ± 2 67 ± 1*** 
glucose 89 ± 2 92 ± 2** 
maltose 85 ± 3 120 ± 2**** 
mannose 129 ± 7 164 ± 7† 
N-acetylglucosamine 84 ± 1 83 ± 1** 
ribose 104 ± 7 108 ± 8** 
cecal mucus 52 ± 3 100 ± 3**** 
 
Each p value refers to a comparison between the generation time of E. coli Nissle 
1917 and E. coli Nissle 1917 envZP41L  when growing on a specific sugar: *, P > 0.05; 
**, P >O.10; ***, P < 0.05, ****, P<0.001, †, P=0.0036.  The table depicts the mean 
generation time for several carbon sources with the standard deviation for each strain 
of E.coli (n=3). 
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Figure 1.  The two-component EnvZ-OmpR system.  EnvZ and OmpR are 
phosphorylated in response to changes in osmotic pressure (24). 
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Figure 2.  Growth of E. coli strains in the presence of 5% bile salts.  Growth was 
performed in LB medium with the addition of 5% bile salts.  Half hour time points 
were collected over 6.5 hours.  Bars represent the standard deviation of the A600, for 
each strain of E. coli for each time point (n=3). 
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Figure 3.  Fifteen day mouse colonization with E. coli Nissle 1917 wildtype StrRNalR 
(■) and E. coli Nissle 1917 envZ(mot-1) StrR (▲).  Two sets of three mice were fed 
105 cfu of E. coli Nissle 1917 envZ(mot-1) and 105 cfu of E. coli Nissle 1917.  At the 
indicated times, fecal samples were homogenized, diluted, and plated as described in 
Materials and Methods.  Bars representing standard errors of the log10 mean of CFU 
per gram of feces are presented for each time point.  
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Figure 4.  Fifteen day mouse colonization with E. coli Nissle 1917 envZ(mot-1) 
StrRNalR (▲) and E. coli Nissle 1917 wildtype StrR (■).  Six sets of three mice were 
fed 105cfu of E. coli Nissle 1917 envZ(mot-1) and 1010 cfu of E. coli Nissle 1917 
wildtype.  At the indicated times, fecal samples were homogenized, diluted, and 
plated as described in Materials and Methods.  Bars representing standard errors of 
the log10 mean of CFU per gram of feces are presented for each time point. 
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Figure 5.  Fifteen day colonization with E. coli Nissle 1917 envZ(mot-1) StrRNalR 
(▲) and E. coli Nissle 1917 wildtype StrRRifR (■).  Three sets of three mice were fed 
105 cfu of E. coli Nissle 1917 and 1010 cfu of E. coli Nissle 1917 envZ(mot-1).  At 
the indicated times, fecal samples were homogenized, diluted, and plated as 
described in Materials and Methods.  Bars representing standard errors of the log10 
mean of CFU per gram of feces are presented for each time point. 
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Figure 6.  Fifteen day colonization with E. coli Nissle 1917 StrR envZ(mot-1) 
restored to wildtype, in respect to envZ, (▲) and E. coli Nissle 1917 wildtype 
StrRNalR (■).  Two sets of three mice were fed 105 cfu of E. coli Nissle 1917 
envZ(mot-1) restored to wildtype and 105 cfu of E. coli Nissle 1917 wildtype.  At the 
indicated times, fecal samples were homogenized, diluted, and plated as 
described in Materials and Methods.  Bars representing standard errors of the log10 
mean of CFU per gram of feces are presented for each time point. 
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Figure 7.  Fifteen day colonization with E. coli Nissle 1917 envZ(mot-1) ∆galK 
StrRCamR (▲) and E. coli Nissle 1917 wildtype StrR (■).  Four sets of three mice 
were fed 105 cfu of E. coli Nissle 1917 envZ(mot-1) ∆galK and 1010 cfu E. coli Nissle 
1917 wildtype.  At the indicated times, fecal samples were homogenized, diluted, 
and plated as described in Materials and Methods.  Bars representing standard 
errors of the log10 mean of CFU per gram of feces are presented for each time point. 
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Figure 8.  Fifteen day colonization with E. coli Nissle 1917 envZ(mot-1) ∆galK 
restored, in respect to ∆galK, StrRNalR (▲) and E. coli Nissle 1917 wildtype StrRRifR 
(■).  Two sets of three mice were fed 105 cfu of E. coli Nissle 1917 envZ(mot-1) 
∆galK and 1010 cfu of E. coli Nissle 1917 wildtype.  At the indicated times, fecal 
samples were homogenized, diluted, and plated as described in Materials and 
Methods.  Bars representing standard errors of the log10 mean of CFU per gram of 
feces are presented for each time point. 
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Figure 9.  Twenty one day colonization with E. coli EDL933 wildtype StrRRifR (▲) 
and E. coli Nissle 1917 wildtype StrRNalR (■).  Three sets of three mice were fed 105 
cfu of E. coli Nissle 1917 wildtype.  On day 10 three sets of three mice were fed 105 
cfu of E. coli EDL933.  At the indicated times, fecal samples were homogenized, 
diluted, and plated as described in Materials and Methods.  Bars representing 
standard errors of the log10 mean of CFU per gram of feces are presented for each 
time point. 
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Figure 10.  Twenty one day colonization with E. coli Nissle 1917 envZ(mot-1) 
StrRNalR (▲) and E. coli EDL933 wildtype StrRRifR (■).  Three sets of three mice 
were fed 105 cfu of E. coli Nissle 1917 envZ(mot-1).  On day 10 three sets of three 
mice were fed 105 cfu of E. coli EDL933.  At the indicated times, fecal samples 
were homogenized, diluted, and plated as described in Materials and Methods.  
Bars representing standard errors of the log10 mean of CFU per gram of feces are 
presented for each time point. 
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Figure 11.  Twenty one day colonization with E. coli Nissle 1917 envZ(mot-1) StrR 
(▲) and E. coli EDL933 wildtype StrRRifR (■) and E. coli Nissle 1917 wildtype 
StrRNalR (●).  Two sets of three mice were fed 105 cfu of E. coli Nissle 1917 
envZ(mot-1) and E. coli Nissle 1917 wildtype.  On day 10 two sets of three mice 
were fed 105 cfu of E. coli EDL933.  At the indicated times, fecal samples were 
homogenized, diluted, and plated as described in Materials and Methods.  Bars 
representing standard errors of the log10 mean of CFU per gram of feces are presented 
for each time point. 
 
 
 
 
 
 
 
 
 
